| Tag | Content |
|---|
EnhancerAtlas ID | HS161-02474 |
Organism | Homo sapiens |
Tissue/cell | PC3 |
Coordinate | chr11:3906490-3908510 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| JUN(var.2) | MA0489.1 | chr11:3907299-3907313 | GTGAGTCATTTCCC | - | 6 | | Zfx | MA0146.2 | chr11:3907993-3908007 | GAGGCCGAGGCGGG | - | 6.01 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_09198 | chr11:3906954-3907852 | CD14 | | SE_09198 | chr11:3908063-3909124 | CD14 | | SE_48193 | chr11:3908304-3909141 | Psoas_Muscle | | SE_61865 | chr11:3873734-3925165 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr11 | 3907028 | 3907194 | | chr11 | 3906913 | 3907590 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH11I003885 | chr11 | 3906831 | 3907630 | | GH11I003886 | chr11 | 3908064 | 3909141 |
|
Enhancer Sequence | CTTGACCTCC CGGGCTCAAC CAATCCTTCC ACTTCAGCCT CCCAAGTAGC TGGGGCTATA 60
GACGTGTGCT AGCCTGGCCA ATTTTTGTAT TATTATTATT ATTTTTTGTA GAGACAGGGT 120
TTTGCCATGT TGCCTAGGCT GGTCTTGAAC CCCTGGGCTC AAGTGATCTG CCTGCCTTGG 180
CCTCCCAAAG TTTGGGATTA CAGGCATGAC CCATAGTGCT CTGCCAAACA TACATAATTT 240
GAGTTTGCTG AGAACTATTG GTTTAACACA ATTGTAGATA ATTATAATTT TCTTTTCTGA 300
TTGGAAGTCT TCTCCCGGTA CTTCAGCTCA CAAAGGTGGA CACATTCCAG TTTTATTTTA 360
TTTTATTTTA TTTATTTTAT CATTTTATTT TTGAGACAGG GACTCGCTCT GTTGTATAGG 420
AGGCTGAAAT ATGGTGGCAC AATCATGGCT CACTGTAGCC TTGACCTCCT TGGCTCAAGT 480
GATTCTCTCA CGTCAGCCTG CTGAGTAGCT GGGACTGCAG GCATGAGCAA CCACACCTGG 540
CTAATTTCTC TATTTTTTGT GTAGACAAAG TCTTACTGTG TTGCCCACGC TGGTGTCAAA 600
CTCCTGGGCT CAAGCAGTCC TCCCGCCTCA GCCTCTGTAA GTGTTGGGAT TACAGGCGTG 660
AGCCACTGTG CGTGGCCCCA TTCCAGTTTT CGATGTGAGT TTGAGCATGA TCGTAGGCAA 720
GGGCCCATCA ATGAAGGTGT TGAGGATATA GCATTGTCCT GCTTTGGCTC AAGGGGACTT 780
TTCCTGCCTT TGATTAAGGA TTGGCATGGG TGAGTCATTT CCCATAGTCT GAGGGATGTG 840
GGATATAAAG AATGAATTGT TATCTCCGAT GATATCTTGA ATATCACACA TTATAGGCCA 900
AATATAGGTG CTAAACCATT TGGCTTGAAT TCTTTATAGA AAATTCACTG GGAACCCAAT 960
GATAAAATAG AGAAAGACGG ATAACCTAAG AGGGAGGAGC AATCTGGTGA GACATTCTTT 1020
TCACCTTTTC ACACATGAGC AATTAAAAAC TTGAGGGAAG TTGATTTTTT TTTTAACTCT 1080
GTAAATAGCT ACTGGTATAA TTCCTTGAGG CTGGTATTGT ATTTTGTGCT ATAAGAAGAG 1140
AGACTTGGCT GGGCGCGGTG GCTCACGCCT GTCATCCCAG CACTTTGGGA GGCCAAGGCA 1200
GGCAGATCAC GAGGTCAGGA GATCGAGACC ACCCTGGATA ACATGGTGAA ACCCTGTCTC 1260
TACTAAAAAT ACAAGAAATT AGCCGGGTGT GGTGGCAGGC ACCTGTAGTC CCAGCTACTC 1320
GGGAGGCTGA GGCAGGAGAA TGGCGTGAAC CTGGGAAGTG GAGCTTGCAG TGAGCAGACA 1380
TCACGCCACC TCACTCCAGC CTGGGTGACA GAGCGAGACT CTGTGTCAAA AAAAAAAAAA 1440
AAAAAAAAAA AGGTCTTATT TGGCCGGGTG CGGTGGCTCA TGCCTGTAAT TCCAGCACTT 1500
TGGGAGGCCG AGGCGGGCGG ATTACGAGGT CAGGAGATCG AGATCATCCT GGATAACATG 1560
GTGAAACCCC GTCTTTACTA AAATACAAAA AATTAGCCAG GTGTGGTGGC GGGTGCCTGT 1620
AATCCTAGCT ACTCAGGAGG CTGAGGCAGT AGAATCACTT TTCACTCAGG AGGCGGAGGT 1680
TGCAGTGAGC CGAGATCGCA CCACTGCACT CCAGCCTGGC GACAGAGCAA GACTCTGTCT 1740
CAAAGAAAAA AAAAAAGAAG AGAGACGGGC CATATACTCA AGGAGTTTCC AAATATATCC 1800
AGAGGTGAAA CAAACATCTA GGATGAAAAG GGTCCAGGGA CTAGTATTGT ACACAGTCAG 1860
AGGAGGTAGA GGGCTGTGAG TTTGGTAATA AGAGAGGAGG CTTGGGAAAC CCAGCCTGAG 1920
TCTAGGTCCA GAGGGCAGCA TGCACTGGGT GAGGGCCTCT AGGGAGAGTA AAGCAGGATA 1980
CATTCTTGTC CTTATACTTC CTTCCCTGTT TCTGTACCTG 2020
|
